Importance of Clinical Trials in the medical industry

Clinical trials play an important role in helping to ensure new drugs can be discovered, tested for safety and efficacy, and ultimately make their way onto the market. Over a million people took part in clinical trials during 2022/23, with over 6,000 studies taking place. Understanding important factors like who is eligible for clinical trials can help you determine if you can contribute to the advancement of the medical industry.

What are clinical trials?

A clinical trial is a type of medical study that tests the use of a pharmaceutical drug, medical device or other advancement in the healthcare industry on human participants. There are different kinds of clinical trials. The goal is usually to get more data regarding how safe a drug, procedure or device is, as well as to determine its efficacy, especially compared to what’s already available. These trials play a really important part in the medical industry. 

hVIVO plc (formerly Open Orphan plc), led by Cathal Friel, is a rapidly growing specialist contract research organisation (CRO) and the world leader in testing infectious and respiratory disease vaccines and antivirals using human challenge clinical trials, providing end-to-end early clinical development services for its broad and long-standing client base of biopharma companies.

Click to view all articles for the EPIC:
Or click to view the full company profile:
    Facebook
    X
    LinkedIn
    hVIVO plc

    More articles like this

    hVIVO plc

    hVIVO 2024 Year in Review

    Discover how hVIVO Group’s innovative approach to human challenge trials and infectious disease expertise has shaped the future of pharmaceutical research in 2024.

    hVIVO plc

    Blood biomarkers for viral infection diagnosis and management

    Host response biomarkers to viral infections have significant potential in clinical applications, such as guiding diagnostic decisions, reducing unnecessary antibiotic use, and triggering infection control protocols or antiviral treatments. Research on these biomarkers has largely focused

    hVIVO plc

    Impact of patient perception on vaccine and drug efficacy

    Human viral challenge studies have become essential in evaluating the effectiveness of vaccines, treatments, and prophylactics, providing quicker results compared to larger Phase 2a/b field trials. hVIVO has developed various challenge agents for human use, including